European Healthcare Expenditure on Medical and Diagnostic Laboratories by Country

In 2024, European healthcare expenditure on medical and diagnostic laboratories shows marked variation across countries. France leads with €13.75 billion, followed by the Netherlands at €2.79 billion. Countries like Portugal, Spain, and the Czech Republic lag behind, with expenditures of €1.7 billion, €0.97 billion, and €0.89 billion, respectively. Minor spenders include Denmark at €0.002 billion and Liechtenstein at €0.011 billion. Year-on-year growth is significant in Estonia (93.33%), Latvia (42.32%), and Bulgaria (39.05%). However, Poland (-3.23%) and Belgium (-6.86%) experienced declines. Over the last five years, these trends reflect a growing need for diagnostic services and fluctuating healthcare priorities.

Future trends to watch include investment in digital health technologies, personalized diagnostics, and expansion of laboratory capacities in response to an ageing population and rising chronic diseases. Monitoring how policies and funding shifts impact smaller markets like Malta, Bosnia, and Herzegovina will also be crucial.

Top countries in Healthcare Expenditure on Medical and Diagnostic Laboratories by Country

# 10 Countries Million Euros Last Year YoY 5-years CAGR
1 1 France 13,750 2023 +21.15% +24.21% View data
2 2 Netherlands 2,790 2023 +27.18% +28.34% View data
3 3 Portugal 1,700 2023 +22.7% +22.67% View data
4 4 Spain 973.65 2023 +1.97% +3.31% View data
5 5 Czech Republic 893.97 2023 +24.08% +26.91% View data
6 6 Switzerland 880.95 2023 +5.27% +6.05% View data
7 7 Austria 532.25 2023 +1.62% +1.34% View data
8 8 Slovakia 470.88 2023 +4.93% +6.95% View data
9 9 Romania 438.88 2023 +6.42% +6.73% View data
10 10 Greece 422.91 2023 -0.31% +4.66% View data

Top Countries about Pathology